Literature DB >> 15197524

Gene expression of cytochromes P450 in liver transplants over time.

Mari Thörn1, Stefan Lundgren, Gustaf Herlenius, Bo-Göran Ericzon, Lars Lööf, Anders Rane.   

Abstract

OBJECTIVE: The aim of this study was to (a) quantify the gene expression of some cytochromes P(450) (CYP), especially CYP3A4, in serial biopsies from liver grafts the first year after orthoptic liver transplantation (OLT) and (b) study the relationship between hepatic CYP3A4 gene expression and plasma levels of cyclosporine and tacrolimus.
METHODS: Liver tissue was obtained from surplus material of routine liver biopsies performed in 20 patients during the first year after OLT. Real-time reverse-transcription polymerase chain reaction was used for quantitative analyses of mRNA specific for CYP3A4, CYP3A5, CYP2E1 and CYP1A2 cytochromes as well as P-glycoprotein (P-gp). The gene expression of beta-actin was used as an internal standard for comparisons between samples.
RESULTS: The median value of the mRNA for all cytochromes, but not for P-gp, was found to increase significantly over time. The gene expression of CYP3A5, CYP2E1 and CYP1A2 was higher than that of CYP3A4. The gene expression of CYP3A4 was related to the plasma concentration of cyclosporine and tacrolimus, i.e. low mRNA concentrations corresponded to high serum concentration levels and vice versa. The serum concentration of bilirubin or the prothrombin index did not correlate with the gene expression level of the cytochromes.
CONCLUSION: The hepatic mRNA expression of CYP3A4 and the other investigated cytochromes increased during the first year after OLT. This was not the case with P-gp. Low CYP3A4 gene expression was related to high plasma levels of cyclosporine and tacrolimus and vice versa.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197524     DOI: 10.1007/s00228-004-0786-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  44 in total

1.  Effect of FK 506 on human hepatic cytochromes P-450: interaction with CyA.

Authors:  L Pichard; I Fabre; J Domergue; H Joyeux; P Maurel
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 2.  Molecular genetics of the P-450 superfamily.

Authors:  F J Gonzalez
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

Review 3.  Pharmacokinetics of cyclosporine: inter- and intra-individual variations and metabolic pathways.

Authors:  M Lemaire; A Fahr; G Maurer
Journal:  Transplant Proc       Date:  1990-06       Impact factor: 1.066

4.  Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease.

Authors:  N Finnström; M Thörn; L Lööf; A Rane
Journal:  Eur J Clin Pharmacol       Date:  2001-08       Impact factor: 2.953

5.  Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine.

Authors:  T Aoyama; S Yamano; D J Waxman; D P Lapenson; U A Meyer; V Fischer; R Tyndale; T Inaba; W Kalow; H V Gelboin
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

6.  Effects of ischemia-reperfusion on individual cytochrome P450 isoforms in the rat kidney.

Authors:  Y Tamura; S Imaoka; M Gemba; Y Funae
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

7.  Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine.

Authors:  K S Lown; R R Mayo; A B Leichtman; H L Hsiao; D K Turgeon; P Schmiedlin-Ren; M B Brown; W Guo; S J Rossi; L Z Benet; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  1997-09       Impact factor: 6.875

8.  Human P-glycoprotein transports cyclosporin A and FK506.

Authors:  T Saeki; K Ueda; Y Tanigawara; R Hori; T Komano
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

9.  Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.

Authors:  Ina Koch; Regina Weil; Renzo Wolbold; Jürgen Brockmöller; Elisabeth Hustert; Oliver Burk; Andreas Nuessler; Peter Neuhaus; Michel Eichelbaum; Ulrich Zanger; Leszek Wojnowski
Journal:  Drug Metab Dispos       Date:  2002-10       Impact factor: 3.922

Review 10.  P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

Authors:  D R Nelson; L Koymans; T Kamataki; J J Stegeman; R Feyereisen; D J Waxman; M R Waterman; O Gotoh; M J Coon; R W Estabrook; I C Gunsalus; D W Nebert
Journal:  Pharmacogenetics       Date:  1996-02
View more
  3 in total

1.  Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract.

Authors:  Mari Thörn; Niklas Finnström; Stefan Lundgren; Anders Rane; Lars Lööf
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

2.  Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation.

Authors:  Pier Luigi Calvo; Loredana Serpe; Andrea Brunati; Antonello Nonnato; Daniela Bongioanni; Dominic Dell' Olio; Michele Pinon; Carlo Ferretti; Francesco Tandoi; Giulia Carbonaro; Mauro Salizzoni; Antonio Amoroso; Renato Romagnoli; Roberto Canaparo
Journal:  Br J Clin Pharmacol       Date:  2017-01-31       Impact factor: 4.335

3.  The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receipts.

Authors:  Jianhai Wang; Keqiu Li; Xiaoning Zhang; Dahong Teng; Mingyan Ju; Yaqing Jing; Yuxia Zhao; Guang Li
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.